Pharma sector sources point out that China's economies of scale result in 20-30 per cent cheaper prices ... DGTR said the probe has been initiated due to a report filed by Indian pharma firms Nectar Life Sciences and Sterile India.
Read more: Government begins anti-dumping probe into pharma imports